He is Chief Executive officer of GHSI. He is among WHO IHR 2005 Experts in Epidemiology and Surveillance and US CDC EIS alumni & adjunct Prof Epi @UNMC
It's #WorldFoodSafetyDay
Unsafe food causes around 866 million illnesses and 1.5 million deaths annually. They make people sick, harms livelihoods and weakens economies.
You can reduce your risk of illness by:
✅ Cooking meat all the way through
✅ Washing fruit and vegetable with safe water
✅ Keeping food at safe temperatures
✅ Eating a varied diet
✅ Choosing smaller fish over large ones
No one should get sick from food https://t.co/g38UohgtDP
The key to ending the #Ebola outbreak in the #DRC area:
Government leadership;
Community ownership;
Strong partnership between the many actors involved, working with one budget, one plan and one report;
And building trust in the affected communities.
Although a bottle of soda may not cost much money, these aren’t cheap calories. Sodas are empty, harmful calories, and around the world they help drive obesity, type 2 diabetes, heart disease, and many other health harms.
I explain why health taxes—on tobacco, alcohol, and sugary drinks—offer a rare triple win. https://t.co/V2Jjj8DlzN
Screworm returns to the US after 60 years. The verdict from Texas “instead of using every available tool, @USDA moved too slowly and relied solely on a partial solution that takes years to fully implement.”
https://t.co/pMtbOSqGJk
@81ShahbazRana Proposed duties on solar panels & EVs show how out of touch the elite bureaucracy is.
People are moving to clean energy, but policy is pushing back—because it threatens fuel levies.
Real issue?
The rich may finally have to pay fair income tax.
https://t.co/6bagH1Kt1G
Proposed duties on solar panels & EVs show how out of touch the elite bureaucracy is.
People are moving to clean energy, but policy is pushing back—because it threatens fuel levies.
Real issue?
The rich may finally have to pay fair income tax.
Proposed duties on solar panels & EVs show how out of touch the elite bureaucracy is.
People are moving to clean energy, but policy is pushing back—because it threatens fuel levies.
Real issue?
The rich may finally have to pay fair income tax.
Smart drug that strips cancer cells of ‘invisibility cloak’ can shrink tumours by 30%, trial shows
In a trial UK, France, Spain and Australia, 83 patients with cervical, bladder, liver, bowel, lung or head and neck cancers were given the experimental drug
https://t.co/WRu6qwm7RL
A new, experimental medication nearly doubled overall survival rates for patients with advanced pancreatic cancer, according to the results of a study published Sunday.
https://t.co/8d4D416b6v
پاکستان کے 50 فیصد کے قریب بچے ذہنی طور پر پسماندہ یا پیچھے رہ رہے ہیں۔
اس کی وجہ غذائیت کی کمی اور سیسا ہے۔
سیسہ کھانے پینے کی اشیاء کی ملاوٹ فیکٹریوں اور پولیوشن اور پرانی بیٹریوں کو کار آمد بنانے کے پراسیس کے اندر پیدا ہوتا ہے۔
https://t.co/OUwLsxUnRh
Presented at #ASCO26:
Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: https://t.co/xwLWBZYRzq
@ASCO
New BMJ Research: Outcome switching in cohort studies of interventions
Almost half of cohort studies of interventions showed outcome switching without a reported rationale, and most of the changes favoured statistically significant results
https://t.co/KjSKlbEhkQ
This Ebola outbreak can be stopped. It will take a response that matches the speed of the virus, not the molasses of bureaucracy. The people who know how to do the work are in place elsewhere. It’s up to the rest of the world to give them the support they need, right now. https://t.co/MKfIMsZkHX
There hasn't previously been a treatment vs pancreatic cancer this successful. Striking improved (a > doubling) survival results @NEJM and @ASCO today with daraxonrasib, which also became available via an FDA approved early access program and began shipping to physicians this week @RevMedicines
https://t.co/e04jqJMPw0
The hope (& hype) of multi-cancer early detection tests dashed in trial after 3 years of the blood test among 142,000 NHS patients. Did NOT lead to fewer late stage cancers. https://t.co/lfruPPY4pf